IRMD.NASDAQIradimed CORP

4/A: Iradimed Director Amends Form 4 Filing to Correct Overstated Share Holdings

Sentiment:

SEC Filing Amendment


James B. Hawkins, a director at Iradimed Corporation, filed an amended Form 4 to correct an overstatement of directly owned shares reported in a previous filing.

Summary

  • James B. Hawkins, a director of Iradimed Corporation, filed an amendment to a previously submitted Form 4.
  • The amendment corrects an error in the original filing from December 10, 2024, which overstated the number of Iradimed Corporation common stock shares directly owned by Hawkins after a transaction.
  • The amended filing clarifies that no transactions were omitted, and the correction addresses only the overstated share count.
  • The transaction date remains December 7, 2024, involving the acquisition of 1,196 shares of common stock.
  • Following the reported transaction, Hawkins beneficially owns 33,545 shares directly.

Sentiment

Score: 7

Explanation: The document is a routine correction of a filing error, indicating a neutral to slightly positive sentiment due to the proactive correction of inaccurate information.

Positives

  • The amended filing ensures accurate reporting of share ownership by a company director.
  • The correction clarifies any potential confusion caused by the initial overstatement.

Management Comments

  • The reporting person timely filed a Form 4, which inadvertently overstated in column 5 the number of shares of Iradimed Corporation (the 'Issuer') common stock directly owned by the reporting person following the reported transaction.
  • No transactions regarding the Issuer's securities were omitted.
  • This inadvertent overstatement has been corrected in this amended filing.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

  • The correction of the filing ensures that shareholders and other stakeholders have accurate information regarding the share ownership of company insiders.

Key Dates

DateDescription
12/07/2024Date of transaction involving the acquisition of Iradimed Corporation common stock.
12/10/2024Date of original Form 4 filing that contained an overstatement of share ownership.
04/04/2025Date of signature on the amended Form 4/A filing.

Keywords

Form 4, Amendment, Share Ownership, Iradimed Corporation, Director, Hawkins, IRMD

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.